Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Rapid Micro Biosystems (RPID) Cost of Revenue (2020 - 2025)

Rapid Micro Biosystems' Cost of Revenue history spans 6 years, with the latest figure at $3.3 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 11.4% to $3.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.1 million, a 8.93% decrease, with the full-year FY2025 number at $12.1 million, down 8.93% from a year prior.
  • Cost of Revenue hit $3.3 million in Q4 2025 for Rapid Micro Biosystems, up from $2.9 million in the prior quarter.
  • Over the last five years, Cost of Revenue for RPID hit a ceiling of $4.1 million in Q4 2022 and a floor of $2.3 million in Q1 2021.
  • Historically, Cost of Revenue has averaged $3.3 million across 5 years, with a median of $3.3 million in 2024.
  • Biggest five-year swings in Cost of Revenue: surged 152.59% in 2021 and later fell 23.35% in 2023.
  • Tracing RPID's Cost of Revenue over 5 years: stood at $3.4 million in 2021, then increased by 22.92% to $4.1 million in 2022, then fell by 23.35% to $3.2 million in 2023, then fell by 5.66% to $3.0 million in 2024, then increased by 11.4% to $3.3 million in 2025.
  • Business Quant data shows Cost of Revenue for RPID at $3.3 million in Q4 2025, $2.9 million in Q3 2025, and $3.1 million in Q2 2025.